Current Gene Therapy
Title:Editorial [Hot Topic :The Therapeutic Sound of Silencing: Managing the Expectations on Targeting RNAi]
Volume: 12 Issue: 4
Author(s): Alexandra Henrion-Caude
Affiliation:
Export Options
About this article
Cite this article as:
Henrion-Caude Alexandra, Editorial [Hot Topic :The Therapeutic Sound of Silencing: Managing the Expectations on Targeting RNAi], Current Gene Therapy 2012; 12 (4) . https://dx.doi.org/10.2174/156652312802083567
DOI https://dx.doi.org/10.2174/156652312802083567 |
Print ISSN 1566-5232 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5631 |
Call for Papers in Thematic Issues
Programmed Cell Death Genes in Oncology: Pioneering Therapeutic and Diagnostic Frontiers (BMS-CGT-2024-HT-45)
Programmed Cell Death (PCD) is recognized as a pivotal biological mechanism with far-reaching effects in the realm of cancer therapy. This complex process encompasses a variety of cell death modalities, including apoptosis, autophagic cell death, pyroptosis, and ferroptosis, each of which contributes to the intricate landscape of cancer development and ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Neuronal Expression of Junctional Adhesion Molecule-C is Essential for Retinal Thickness and Photoreceptor Survival
Current Molecular Medicine Construction and Evaluation of Liraglutide Delivery System based on Milk Exosomes: A New Idea for Oral Peptide Delivery
Current Pharmaceutical Biotechnology Polyphenols: A Nutraceutical Approach Against Diseases
Recent Patents on Food, Nutrition & Agriculture The Pathophysiological Role of PEDF in Bone Diseases
Current Molecular Medicine Targeting the Type I Insulin-Like Growth Factor System for Breast Cancer Therapy
Current Drug Targets Peptide Prodrugs for the Treatment of CNS Disorders: A Perspective for New Drugs
Current Medicinal Chemistry Matrix Gelatinases in Atherosclerosis and Diabetic Nephropathy: Progress and Challenges
Current Vascular Pharmacology The High Mobility Group A1 (HMGA1) Transcriptome in Cancer and Development
Current Molecular Medicine Development of Aptamer-Based Nanomaterials for Biological Analysis
Current Molecular Medicine Autophagy in Invertebrates: Insights Into Development, Regeneration and Body Remodeling
Current Pharmaceutical Design Prolyl-Specific Peptidases and Their Inhibitors in Biological Processes
Current Chemical Biology Melatonin Therapy of Pediatric Sleep Disorders: Recent Advances, Why it Works, Who are the Candidates and How to Treat
Current Pediatric Reviews Editorial (Theamtic Issue: Cell-in-Cell: A Century-Old Mystery Comes to the Table)
Current Molecular Medicine Current and Future Challenges in Primary Sjogren’s Syndrome
Current Pharmaceutical Biotechnology Immunosuppressant Drugs and Covid-19: Associated Risks, Drug-Drug Interactions and Contraindications
Coronaviruses The Role of Alpha-lipoic Acid Supplementation in the Prevention of Diabetes Complications: A Comprehensive Review of Clinical Trials
Current Diabetes Reviews Recent Developments in CE-MS Based Metabolomics
Current Analytical Chemistry Herbal Insomnia Medications that Target GABAergic Systems: A Review of the Psychopharmacological Evidence
Current Neuropharmacology Mitochondria in Cancer Stem Cells: A Target for Therapy
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) From Virus Evolution to Vector Revolution: Use of Naturally Occurring Serotypes of Adeno-associated Virus (AAV) as Novel Vectors for Human Gene Therapy
Current Gene Therapy